Perlu Network score measures the extent of a member’s network on Perlu based on their connections, Packs, and Collab activity.
FOR FASTER SERVICE, PLEASE CONTACT YOUR COMPANY'S TRAVEL OFFICE OR TRAVEL AGENT. THANK YOU.
BCD Travel’s Life Sciences Center of Excellence today announced an enhanced approach to clinical trial patient travel aimed at shifting the paradigm from traditional service delivery. BCD is keenly aware of the importance of patient centricity for our customer and recognizes the significant physical, emotional and financial burdens that can be associated with trial participation,” said Jessica Azoulay, Vice President, Life Sciences Center of Excellence. That’s why we are excited to deliver solutions that address this unmet need in ways that will improve patient centricity and reduce trial attrition.” With more than 20 years of experience and deep institutional knowledge across 40+ therapeutic areas, BCD is the largest life sciences travel, meetings and consultancy organization. With more than 20 customers in the patient space, BCD’s heightened focus on this population extends across all patient interactions to include patient advocacy, clinical trial participation, improved payment and reimbursement solutions, all with associated communications and campaign strategies that enhance patient engagement.
The path forward: Health essentials that will drive business travelTo re-open borders without quarantine and resume safe travel, both travellers and governments need to be confident that they are effectively mitigating the risk of COVID-19 infection. But are vaccines the only consideration for travellers itching to get back on the road? Register today to hear from our experts: can other regulatory measures like travel corridors and tracing apps support travel’s return?Are business travellers planning to take the vaccine?
Skip to content Date: Wednesday, March 24 Time: 12am ET Join us to hear from travel experts in the health care world who have adapted to this new environment. They’ll share their perspective and experience on breaking traditional models and balancing corporate programs with the delicate, complex and specific needs of their traveling populations. In 30 minutes we’ll discuss:Why an integrated travel and meetings approach is importantThe need for program transparency, and how to realize itHow to put your customer first, while assuring compliance and duty of care
Since the U. K.’s exit from the EU (European Union), rules affecting business travel between the U.K. and EU, Iceland, Liechtenstein, Norway and Switzerland (collectively referred to in this report as Europe) have changed, largely as a result of the EU-UK Trade and Cooperation Agreement. Changes mostly affect U.K. citizens making trips to Europe, but business travel from Europe to the U.K. will see some changes too. And these changes may apply not just to U.K. and European citizens; anyone traveling for business between Europe and the U.K. could be affected under some circumstances. This document summarizes some of the key changes that travel managers and travelers need to look out for.